Insurance coverage for weight loss drugs like Zepbound and Wegovy is becoming increasingly difficult due to high costs. As of 2026, 24 million people have had their plans drop coverage for these medications, with 12 million each losing coverage for Zepbound and Wegovy. To navigate this issue, patients can work with their doctors to identify qualifying conditions, such as obstructive sleep apnea or diabetes, and file appeals to get their medication approved.
Original Article Source Link:
https://www.npr.org/2026/06/23/nx-s1-5793971/weight-loss-glp1-insurance-coverage